← Open Payments lookup

KRISTINA JIMENEZ: Open Payments

NPI 1952776023 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,392 in 130 payments from 21 companies in 2025. Trend: 2023 $679 · 2024 $2,761 · 2025 $2,392

Food & beverage: $2,392
CompanyPaymentsAmount
ABBVIE INC.31$462
Janssen Biotech, Inc.16$385
Aimmune Therapeutics, Inc.20$228
Ardelyx, Inc.8$227
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$191
Takeda Pharmaceuticals U.S.A., Inc.8$164
Gilead Sciences, Inc.7$120
Madrigal Pharmaceuticals4$115
Ipsen Biopharmaceuticals, Inc4$114
GENZYME CORPORATION3$79

Products named: TREMFYA, IBSRELA, VOWST, XIFAXAN, RINVOQ, LINZESS, ENTYVIO, REZDIFFRA.

Industry payments across AZ — which companies pay providers there.